Medicine and Dentistry
Adenocarcinoma
29%
Adenoma
8%
Anal Canal
11%
Anal Verge
17%
Bowel Obstruction
10%
Cancer Surgery
11%
Chemoradiotherapy
15%
Colectomy
20%
Colon
9%
Colon Carcinoma
12%
Colon Surgery
10%
Colorectal Carcinoma
19%
Colorectal Surgery
16%
Colostomy
9%
Diverticulitis
21%
End to End Anastomosis
9%
Endoscopic Surgery
10%
Hemicolectomy
11%
Laparoscopic Surgery
16%
Local Excision
14%
Morbidity
10%
Neoplasm
45%
Noninferiority Trial
10%
Observational Study
46%
Obstruction
9%
Operation Duration
13%
Outpatient
13%
Parastomal Hernia
15%
Peritoneal Cavity
9%
Postoperative Complication
31%
Prospective Cohort Study
10%
Randomized Clinical Trial
10%
Randomized Controlled Trial
17%
Rectum Adenoma
21%
Rectum Cancer
42%
Rectum Carcinoma
10%
Rectum Tumor
48%
Recurrence Risk
11%
Recurrent Disease
35%
Sphincter
12%
Submucosa
8%
Surgeon
17%
Surgery
44%
Surgical Anastomosis
28%
Surgical Infection
13%
Surgical Margin
9%
Suture
13%
Total Mesorectal Excision
36%
Transanal Endoscopic Microsurgery
95%
Transanal Endoscopic Surgery
83%
Keyphrases
Acute Diverticulitis
21%
Adenocarcinoma
29%
Adenoma
11%
Anal Canal
11%
Anal Verge
19%
Anastomosis
26%
Colon Surgery
10%
Colorectal Cancer
36%
Colorectal Surgery
25%
CoMoS
9%
Confidence Interval
11%
Consecutive Patients
10%
Excision
11%
Hospital Stay
12%
Inclusion Criteria
10%
Intracorporeal
21%
Intracorporeal Anastomosis
11%
Laparoscopic Approach
15%
Left Colon
12%
Left-handed
11%
Left-sided Colectomy
10%
Local Recurrence
12%
Local Surgery
12%
Long-term Oncological Outcomes
9%
Morbidity Rate
10%
Non-inferiority Trial
10%
Outpatient Treatment
9%
Pacientes
13%
Parastomal Hernia
15%
Perforation
11%
Peritoneal Cavity
9%
Postoperative Complications
23%
Postoperative Morbidity
12%
Prospective Data Collection
16%
Prospective Randomized Trial
13%
Randomized Controlled Trial
10%
Rectal Adenocarcinoma
15%
Rectal Adenoma
18%
Rectal Prolapse
11%
Rectal Tumor
49%
Resection
32%
Robotics
10%
Surgeons
12%
Surgical Time
11%
Transanal
18%
Transanal Endoscopic Microsurgery
100%
Transanal Endoscopic Operation
17%
Transanal Endoscopic Surgery
87%
Transanal Total Mesorectal Excision (taTME)
36%
Tumor
22%